关注
Dr. Iyad Naeem Muhammad
Dr. Iyad Naeem Muhammad
Associate Professor in the Department of Pharmaceutics, University of Karachi
在 uok.edu.pk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Development of HPLC-UV method for analysis of cefixime in raw materials and in capsule
H Arshad, S Gauhar, R Bano, I Muhammad
Jordan journal of pharmaceutical sciences 2 (1), 2009
532009
MRSA: Prevalence and susceptibility pattern in health care setups of Karachi
T Siddiqui, IN Muhammad, MN Khan, S Naz, L Bashir, N Sarosh, ...
Pak J Pharm Sci 30 (6), 2417-2421, 2017
272017
Development and pharmaceutical evaluation of oral fast dissolving thin film of escitalopram: A patient friendly dosage form.
M Mushtaque, IN Muhammad, SMF Hassan, A Ali, R Masood
Pakistan journal of pharmaceutical sciences 33 (1), 2020
242020
Formulation Design and Optimization of Aceclofenac Tablets (100 mg) Using Central Composite Design with Response Surface Methodology
B Rabia, S Muhammad H, H ALI, F ZAFAR, MI NAEEM, N ASLAM, ...
Lat. Am. J. Pharm. 33 (6), 1009-1018, 2014
232014
Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies
M Hanif, MH Shoaib, RI Yousuf, S Sattar, M Nadeem, L Hussain, MU Zia, ...
Pak J Pharm Sci 27 (4), 785-92, 2014
212014
High performance liquid chromatographic determination of naproxen in prepared pharmaceutical dosage form and human plasma and its application to pharmacokinetic study
S Muneer, IN Muhammad, MA Abrar, I Munir, I Kaukab, A Sagheer, ...
J. Chromatogr. Sep. Tech 8 (3), 1-5, 2017
182017
Use of hydrophilic and hydrophobic polymers for the development of controlled release tizanidine matrix tablets
T Ali, MH Shoaib, RI Yousuf, S Jabeen, IN Muhammad, A Tariq
Brazilian Journal of Pharmaceutical Sciences 50 (4), 799-818, 2014
182014
Aceclofenac: A New Effective and Safe NSAID
R Bushra, MH Shoaib, MI Naeem, N Aslam
International journal of Drug Discovery and Technology 4 (1), 34-42, 2013
152013
Comparative studies of ciprofloxacin 250 mg tablets available in Pakistani market
A Hussain, M Hanif, MH Shoaib, RI Yousuf, T Ali, IN Muhammad, ...
Lat Am J Pharm 32 (4), 484-89, 2013
152013
Formulation development and optimization of nimesulide tablets by central composit design and effect of surfactants on dissolution studies
M Hanif, M Harris, I Rabia, S Shahnila
J Pharm Res 4 (7), 2447-2452, 2011
152011
Determination of cefadroxil in tablet/capsule formulations by a validated reverse phase high performance liquid chromatographic method
N Rahim, SB Naqvi, S Shakeel, W Iffat, IN Muhammad
Pak. J. Pharm. Sci 28 (4), 1345-1349, 2015
142015
Formulation development and optimization of cefuroxime axetil tablets by direct compression method and its stability studies
IN Muhammad, MH Shoaib, IY Rabia, M Hanif, S Jabeen, T Ali
Lat. Am. J. Pharm 31 (2), 271-278, 2012
142012
Pediatric Nosocomial infections: Resistance pattern of Clinical isolates.
NM Iyad, BS Naqvi, K Hashmi, S Gauher
Pak. J. Pharm. Sci. 19 (1), 52–57, 2006
142006
Hospital Antibiotic Stewardship Programs-Qualitative analysis of numerous hospitals in a developing country
M Mushtaque, F Khalid, AA Ishaqui, R Masood, MB Maqsood, ...
Infection Prevention in Practice 1 (3-4), 100025, 2019
132019
Development and Validation of a HPLC Method for Determination of Pefloxacin in Tablet and Human Plasma
G Shahnaz, AA Syed, S Harris, BSN Syed, NM Iyad
Iranian Journal of Basic Medical Sciences 12 (1), 33-42, 2009
132009
Phenotypic expression and prevalence of multi drug resistant extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in Karachi, Pakistan
S Fatima, IN Muhammad, MN Khan, S Jamil
Pak J Pharm Sci 31 (4), 1379-84, 2018
102018
UNNATURAL DEATHS: PATTERN OF UNNATURAL DEATHS IN FAISALABAD.
H Parveen, M Naeem, MI Pal, J Iqbal, I Hussain
The Professional Medical Journal 25 (02), 321-324, 2018
102018
Novelty and Compliance of Oral Fast Dissolving Thin Film–A Patient Friendly Dosage Form
M Mushtaque, IN Muhammad, SK Ali, F Khalid, R Masood
Clin Pharmacol Biopharm 10 (211), 2, 2021
92021
Use of eudragit RS PO, HPMC K100M, ethyl cellulose, and their combination for controlling nicorandil release from the bilayer tablets with atorvastatin as an immediate-release …
W Iffat, MH Shoaib, RI Yousuf, F Qazi, ZA Mahmood, IN Muhammad, ...
Journal of Pharmaceutical Innovation, 1-20, 2020
92020
Development and validation of HPLC method for the determination of Candesartan in human plasma
S Hamid, AE Beg, IN Muhammad, S Hassan, A Hassan, A Akram, ...
Pak J Pharm Sci 31 (6), 2323-2327, 2018
92018
系统目前无法执行此操作,请稍后再试。
文章 1–20